BamSEC and AlphaSense Join Forces
Learn More

Treace Medical Concepts Inc. – Material Contracts

NASDAQ: TMCI    
Share price (6/26/26): $4.46    
Market cap (6/26/26): $289 million

Material Contracts Filter

EX-10.2
from 10-Q 9 pages Certain Information Contained in This Document Has Been Omitted Because It Is (I) Not Material and (II) the Type That the Registrant Treats as Private or Confidential. Omitted Portions Are Marked With “[***]” in This Exhibit. Consulting Services Agreement
12/34/56
EX-10.16
from 10-K 4 pages Treace Medical Concepts, Inc. Non-Employee Director Compensation Program Amended and Restated as of January 17, 2024 and Amended as of August 1, 2024, February 19, 2025 and February 18, 2026
12/34/56
EX-10.1
from 10-Q 3 pages Certain Identified Information in This Document Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omitted Portions Are Marked With “[***]” in This Exhibit
12/34/56
EX-10.3
from 10-Q 3 pages Certain Identified Information in This Document Has Been Omitted in Accordance With Item 601(b)(10) of Regulation S-K Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omitted Portions Are Marked With “[***]” in This Exhibit
12/34/56
EX-10.15
from 10-K 4 pages Treace Medical Concepts, Inc. Non-Employee Director Compensation Program Amended and Restated as of January 17, 2024 and Amended as of August 1, 2024 and February 19, 2025
12/34/56
EX-10.6
from 10-K 12 pages Change in Control Severance Agreement
12/34/56
EX-10.14
from 10-K 4 pages Treace Medical Concepts, Inc. Non-Employee Director Compensation Program Amended and Restated as of January 17, 2024
12/34/56
EX-10.1
from 10-Q 12 pages Treace Medical Concepts, Inc. 2021 Incentive Award Plan Performance Stock Unit Award Grant Notice
12/34/56
EX-10
from 10-K 4 pages Treace Medical Concepts, Inc. Non-Employee Director Compensation Program Amended and Restated December 13, 2022, as Amended on January 20, 2023
12/34/56
EX-10.2
from 10-Q 128 pages Certain Information Contained in This Document Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omitted Portions Are Marked With “[***]” in This Exhibit
12/34/56
EX-10.1
from 10-Q 134 pages Certain Information Contained in This Document Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. Omitted Portions Are Marked With “[***]” in This Exhibit
12/34/56
EX-10.20
from 10-K 3 pages Amended and Restated Director Compensation Program
12/34/56
EX-10.12
from 10-K 6 pages Release and Consulting Agreement
12/34/56
EX-10.7
from 10-K 13 pages Change in Control Severance Agreement
12/34/56
EX-10.3
from 10-Q 16 pages Change in Control Severance Agreement
12/34/56
EX-10.2
from 10-Q 16 pages Change in Control Severance Agreement
12/34/56
EX-10.1
from 10-Q 3 pages Release Agreement
12/34/56
EX-10.7
from 10-Q 16 pages Change in Control Severance Agreement
12/34/56
EX-10.6
from 10-Q 16 pages Change in Control Severance Agreement
12/34/56
EX-10.5
from 10-Q 16 pages Change in Control Severance Agreement
12/34/56